- New methodology of TMB assessment from tissue and liquid biopsy in NSCLC2022 | First Faculty of Medicine
- Tumor mutation burden - a clinical oncologist's perspective2019 | First Faculty of Medicine
- Circulating Cell-Free DNA Extraction from Liquid Biopsy for Cancer Research2022 | First Faculty of Medicine
- NUT midline pulmonary carcinoma - molecular profiling of three cases and a literature review of the per-spectives for precision oncology2023 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Tebentafusp2022 | Faculty of Medicine in Pilsen
- ELISA kit for the detection of MUC1-fs proteinPublication without faculty affiliation
- Imunooncologic therapeutic options in small cell lung cancer (SCLC) therapy2020 | Faculty of Medicine in Pilsen
- Immunotherapy in the first line treatment of non-small cell lung cancer2020 | Faculty of Medicine in Pilsen
- High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases2023 | First Faculty of Medicine, Third Faculty of Medicine
- Did the Boreal Realm extend into the equatorial region? New paleomagnetic evidence from the Tuva-Mongol and Amuria blocks2021 | Faculty of Science
- An autologous dendritic cell vaccine promotes anticancer immunity in patients with ovarian cancer with low mutational burden and cold tumors2022 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- A rapid ELISA method for the detection of sarcosine using pseudoperoxidase activity of gold nanoparticles2018 | Faculty of Science
- Clear cell renal cell carcinoma with prominent microvascular hyperplasia: Morphologic, immunohistochemical and molecular-genetic analysis of 7 sporadic cases2022 | Faculty of Medicine in Pilsen
- The significance of the fusion partner gene genomic neighborhood analysis in translocation-defined tumors2022 | Faculty of Medicine in Pilsen
- Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 2382023 | Third Faculty of Medicine
- A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease2020 | Faculty of Medicine in Pilsen